To discuss the many issues involved in cervical cancer diagnosis and prevention, especially vaccination. For example, does vaccination against 2 HR-HPV genotypes really prevent cervix cancer, can it cause cervix cancer if the vaccinated woman is already a carrier of HPV, and how do you monitor vaccination programmes? Also important issues on improving cervix cancer detection programmes and how P16 increases accuracy of cytology and histology results.